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SUMMARY – Th e incidence of pregnancy related diabetes has been steadily increasing during 
the past decade. Th e aim of this retrospective study was to evaluate the type and prevalence of gesta-
tional diabetes complications after implementing new diagnostic criteria for gestational diabetes. Th e 
incidence of gestational diabetes, maternal age, mode of delivery and birth weight were analyzed. 
Study patients were divided into three groups. Th e fi rst group consisted of patients who gave birth 
during 2005, the second group during 2011 and the third group during 2012. In 2005, the World 
Health Organization criteria were used on diagnosing gestational diabetes, whereas in 2011 and 2012 
the criteria issued by the International Association of Diabetes and Pregnancy Study Groups were 
considered. Th ere was no statistically signifi cant diff erence among the groups according to maternal 
age, birth weight (p=0.203) and mode of delivery (p=0.883). Cesarean section was performed in about 
30% of deliveries in all groups combined. Th ere was no signifi cant diff erence in the number of neona-
tal hypertrophy (p=0.348), although the distribution of hypertrophy showed a tendency towards high-
er values in 2005. Th e incidence of gestational diabetes was 2.2% in 2005, 6.6% in 2011 and 12% in 
2012. In conclusion, diff erence in the incidence of pregnancy related diabetes appeared to have re-
sulted directly from using diff erent diagnostic criteria. Th e new criteria contributed to a relatively 
higher incidence of gestational diabetes but also achieved better gestational glycemic control and 
consequently better fetal growth regulation.
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Introduction
Diabetes mellitus type 2 is nowadays a widespread 
condition in the general population with potentially 
numerous complications. New diagnostic criteria may 
infl uence the incidence and possibly outcomes as well. 
Undertreated gestational diabetes can lead to various 
complications of pregnancy, labor and perinatal out-
come with long lasting repercussions. Gestational dia-
betes is diabetes fi rst diagnosed during pregnancy. Th e 
defi nition includes previously unrecognized diabetes 
and impaired glucose tolerance1,2. Obesity and distur-
bances of carbohydrate metabolism are the main rea-
sons for the increased incidence of gestational diabetes.
Diagnostic criteria for gestational diabetes vary 
widely. Until 2010, the most often used criteria were the 
World Health Organization (WHO) guidelines in-
cluding oral glucose tolerance test (OGTT) from capil-
lary blood glucose 6.1 mmol/L and 7.8 mmol/L after 2 
hours, measured during the third trimester after ultra-
sonic proof of fetal hypertrophy, polyhydramnion or 
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placental changes3. Th is enabled detection of gestational 
diabetes mostly during the second half of pregnancy, 
and the need for earlier diagnosis was recognized. Chan-
ging the criteria should have especially been focused on 
ensuring early diagnosis and proper management before 
the onset of gestational diabetes complications.
Th e International Association of Diabetes and 
Pregnancy Study Groups (IADPSG) has assembled 
guidelines that can be used as refi ned diagnostic cri-
teria and has classifi ed gestational diabetes based on 
the Hyperglycemia and Adverse Pregnancy Outcome 
study (HAPO study) that recommends diagnosing 
gestational diabetes based on venous plasma glucose 
values4. Th e results indicate the diagnosis when fasting 
venous plasma glucose up to 20 weeks of pregnancy is 
≥5.1 mmol/L. Th is should be supported with the 
OGTT; when done at 24-32 weeks of gestation, fast-
ing venous plasma glucose should be ≥5.1 mmol/L, 
followed by ≥10.0 mmol/L after 1 hour and fi nally 
≥8.5 mmol/L 2 hours after glucose intake. If one or 
more of these values are equal or higher after 75-g 
OGTT, the diagnosis of gestational diabetes should be 
established. Overt diabetes can be diagnosed when 
fasting plasma glucose is ≥7.0 mmol/L, HbA1c level 
≥6.5% or random plasma glucose over 11.1 mmol/L5.
Th e aim of this retrospective study was to evaluate 
the type and incidence of gestational diabetes compli-
cations after implementation of the new diagnostic 
criteria for gestational diabetes at the Department of 
Obstetrics, Sestre milosrdnice University Hospital 
Center in Zagreb, Croatia.
Patients and Methods
Data from the maternity ward were retrospectively 
collected. Th e age of diabetic mothers, body mass in-
dex (BMI), gestational weight gain, mode of delivery 
and birth weight recorded in 2005 were compared 
with those recorded in 2011 and 2012. In 2005, the 
WHO criteria were used for detection of gestational 
diabetes, whereas in 2011 and 2012 the HAPO study 
guidelines were implemented. Statistical analyses were 
performed by the SPSS version 13.0 (SPSS, Chicago, 
IL, USA) using Student’s t-test and c2-test.
Results
Total number of deliveries in 2005 was 2359, of 
which 52 (2.2%) women were diagnosed with gesta-
tional diabetes. In 2011, total number of deliveries was 
3250 with a 6.6% incidence of gestational diabetes 
(n=214). In 2012, 3157 women delivered in our Hos-
pital and the number of patients with gestational dia-
betes increased to 12% (n=379). Th e mean age of pa-
tients from all three groups was 31±4.3 years. Median 
BMI in all groups was the same, i.e. 22 before preg-
nancy and 27 upon admission to the hospital for deliv-
ery. However, median weight gain during pregnancy in 
2011 and 2012 was 12 kg as compared with 14 kg in 
2005. Th e mean maternal body weight at the begin-
ning of pregnancy was 61 kg.
Fig. 1. Mean birth weight.
Fig. 2. Mode of delivery (%).
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Th e mean neonatal birth weight in the group with 
gestational diabetes was 3584 g in 2005, 3487 g in 
2011 and 3457 g in 2012 (Fig. 1). Analysis of variance 
yielded no signifi cant between-group diff erence 
(F=1.601; df=2; p=0.203).
Cesarean section was the mode of delivery in 26.9% 
of deliveries in 2005, 30.4% in 2011 and 29.6% in 
2012 (Fig. 2), with no signifi cant between-group dif-
ference (c2=0.248; df=2; p=0.883).
Ten (19.2%), 26 (12.0%) and 47 (12.4% patients 
with gestational diabetes gave birth to hypertrophic 
newborns in 2005, 2011 and 2012, respectively. Th ere 
was no between-group diff erence in birth weight (c2=
2.110; df=2; p=0.348) (Fig. 3).
In 2005, there were 7.7% of newborns weighing 
4250 g or more, in 2011 their percentage decreased to 
4.2%, and in 2012 it was 4.5%. Th e 3750-4249 g 
weight group accounted for 36.5% of newborns in 
2005, 24% in 2011 and 21.1% in 2012. Th ere was a 
signifi cant diff erence between the 2005 and 2011 
groups, as well as between 2005 and 2012 groups 
(p<0.05 both).
Indications for cesarean section in 2005, 2011 and 
2012 are shown in Figure 4. Due to the sample char-
acteristics, no statistical test other than descriptive sta-
tistics could be employed for this parameter.
Discussion
Th e growing incidence of obesity and carbohydrate 
metabolic disorders poses a major problem in pregnant 
women with gestational diabetes6. Repercussions of 
gestational diabetes include fetal macrosomia, birth 
trauma to both mother and newborn, the need of labor 
induction or cesarean section, transient neonatal mor-
bidity, neonatal hypoglycemia, perinatal death, obesity 
and/or diabetes developing later in the newborn’s life. 
Fig. 4. Indications 
for cesarean section.
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Th e incidence varies among ethnic groups, increases 
with obesity, maternal age and known genetic predis-
position7,8. Th e criteria for diagnosing diabetes in 
pregnant women are diff erent from those in general 
population. In the beginning of pregnancy, increasing 
hormone levels exert combined proinsulin and ana-
bolic actions, while later during pregnancy, diabeto-
genic hormones infl uence glucose utilization, especial-
ly in third trimester, and increase insulin utilization by 
more than fourfold. If there is already weakness of 
pancreatic beta cell islets of Langerhans, diff erent de-
grees of glucose intolerance will manifest3,9. Th ere are 
no uniform criteria for the diagnosis of gestational 
diabetes. O’Sullivan’s OGTT criteria, the National 
Diabetes Data Group (NDDG) criteria and WHO 
criteria can be used for successful detection of a por-
tion of pregnant women with diabetes3. Th e HAPO 
study was launched to explain the observed clinical 
trend of poor outcomes in pregnancies with diff erent 
grades of glucose intolerance. Conclusions of the 
HAPO study stated that the incidence of high birth 
weight, C-peptide levels in the umbilical cord, or the 
percentage of fat in the body weight of a fetus greater 
than 90 percentile was twofold greater if glucose value 
was equal to or higher than the limit value. Th e inci-
dence of preeclampsia was twice higher if one or more 
glucose values were equal to or higher than the limit 
values and the incidence of premature births and pri-
mary cesarean sections was higher than 45%. Since 
2011, the IADPSG criteria are in use in our Depart-
ment. Th ese guidelines contribute to better risk group 
identifi cation and stratifi cation, but also change the 
method and extent of monitoring a large number of 
pregnant women10-12.
In our Department, the incidence of gestational 
diabetes was 2.2% in 2005, 6.6% in 2011 and 12.0% in 
2012. In the HAPO study, the overall percentage of 
pregnant women with gestational diabetes was 17.8%. 
Due to the changed criteria for gestational diabetes, in 
2005 we had only 2.2% of patients with gestational 
diabetes in comparison with 2011 and 2012 when the 
new and stricter criteria were applied. Th e diff erence in 
the incidence between 2011 and 2012 can be explained 
by further adjusting the implementation of the new 
criteria. A large Chinese study compared the incidence 
and outcome of pregnancy under NDDG and 
IADPSG criteria. Th e prevalence of gestational diabe-
tes when using IADPSG criteria was 18.9%. Th e prev-
alence of cesarean section, macrosomia, hypoglycemia, 
neonatal and perinatal death was signifi cantly lower 
when the IADPSG criteria were used13. Th e rate of 
cesarean sections in the group with IADPSG criteria 
was 46% and was signifi cantly lower than in the group 
with NDDG criteria. In our study population, the 
mean weight at the beginning of pregnancy was 61 kg 
in all groups, while at the end of pregnancy it was 74 
kg in 2005 and 72 kg in 2011 and 2012. We found no 
statistically signifi cant diff erence in the maternal mean 
weight or BMI among the three groups, but there was 
a slight decrease of gestational weight gain in 2011 
and 2012. Th ese data may indicate better dietary con-
trol and therefore lower weight gain in the 2011 and 
2012 groups. In our study, cesarean section was per-
formed in 30% of patients regardless of the criteria ap-
plied. Th e median weight of neonates did not diff er 
signifi cantly between the 2011 and 2012 groups, yet 
showing a decreasing tendency, but we found signifi -
cant diff erence in the 3750-4249 g group (p<0.05) be-
tween 2005 and 2011, as well as between 2005 and 
2012. Although there was no signifi cant diff erence in 
the number of macrosomic children between these 
groups, we also observed a decreasing tendency in 
2011 and 2012 as compared with 2005. Th ese results 
indicate better glycemic control in mothers and there-
fore a decreased number of hypertrophic children in 
2011 and 2012.
Th e percentage of macrosomic children in the Chi-
nese study and our study using IADPSG criteria was 
similar (6.3% and 7.6%, respectively). Th e increase in 
the number of pregnant women with gestational dia-
betes is an additional fi nancial burden on the health-
care system but it brings long-term savings by prevent-
ing morbidity both during pregnancy and in the child’s 
later life14,15. Newborns of mothers with gestational 
diabetes have a higher risk of developing psychomotor 
disorders and schizophrenia. Th is alone should en-
courage monitoring and treating even mild hypergly-
cemia in pregnancy, as evidenced by the ACHOIS and 
MFMU studies16,17. Th e high prevalence of gestational 
diabetes can be explained by the worldwide epidemic 
of obesity, prediabetes and diabetes18.
Although we have tried to utilize uniform criteria 
for timely and accurate diagnosis and monitoring of 
pregnant women with gestational diabetes, it seems 
that the process will not always go as anticipated due 
to many resistances to introducing new criteria. Al-
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though the results of HAPO study clearly show a 
lower incidence of macrosomic children, preeclampsia, 
preterm delivery, shoulder dystocia and birth injuries, 
the methodology and results of the HAPO study are 
under constant criticism19. Th e US National Institute 
of Health has not accepted the IADPSG recommen-
dations, deeming the consequent prevalence of gesta-
tional diabetes too high and without objective justifi -
cation. Th ey are actively working on the adoption and 
refi ning their own guidelines20,21. It should be noted 
that no clinical study showed negative eff ect of utiliz-
ing the IADPSG based treatment of gestational dia-
betes. On the contrary, the results of the HAPO study 
clearly put the fetus in the center of interest in preg-
nant women with gestational diabetes and stress the 
importance of observing the fetus as a patient. Th e im-
portance of maintaining an optimal intrauterine envi-
ronment is not only a prerequisite for good perinatal 
outcome, but also provides conditions that encourage 
full development of fetal potential and minimize late 
eff ects of gestational diabetes. It is known that chil-
dren from unregulated pregnancies with gestational 
diabetes often develop obesity, metabolic syndrome 
and have diffi  culties with social intercourse. Th is con-
cept of fetal programming has been studied widely in 
clinical, epidemiological and animal studies22,23.
During the few months of pregnancy, the diagnosis 
and treatment of gestational diabetes do not endanger 
the health and life of pregnant women, but it might be 
an additional motivation to adopt healthy habits and a 
quality lifestyle after pregnancy. Th is is the best way to 
prevent the development of diabetes type 2, to which 
many of the healthy and especially gestational diabetes 
women are predisposed to develop later in life.
Conclusion
In our study, no signifi cant diff erences in birth 
weight and mode of delivery were found in patients 
with gestational diabetes according to the two diff er-
ent diagnostic criteria. Th ere was, however, a signifi -
cant diff erence in the distribution of higher birth 
weight, showing the use of the IADPSG criteria to be 
associated with lower neonatal weight values in pa-
tients with gestational diabetes. Th e incidence trends 
similar to the HAPO study results can be expected in 
the future. In 2011 and 2012, better maternal glycemic 
control and therefore a decreased number of hypertro-
phic children were recorded. We found no statistically 
signifi cant diff erence in the maternal mean weight and 
BMI among the three groups, but there was a slight 
decrease of gestational weight gain in 2011 and 2012. 
Th ese data may indicate better dietary control and 
therefore lower weight gain in the 2011 and 2012 
groups. Although these new diagnostic criteria have 
not been widely accepted, our results showed benefi ts 
for both the mother and the baby.
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Sažetak
UTJEČU LI NOVI DIJAGNOSTIČKI KRITERIJI ZA GESTACIJSKI DIJABETES 
NA ISHOD TRUDNOĆA?
I. Djaković, S. Sabolović Rudman, V. Gall, A. Košec, M. Markuš Sandrić i V. Košec
Incidencija gestacijskog dijabetesa je u stalnom porastu u proteklom desetljeću. Cilj ove retrospektivne studije bio je 
utvrditi komplikacije gestacijskog dijabetesa i ishode trudnoća nakon promjene kriterija za dijagnozu gestacijskog dijebetesa. 
Analizirana je incidencija dijabetesa u trudnoći, dob majki, način dovršenja porođaja i težina novorođenčadi. Ispitanice su bile 
podijeljene u tri skupine. U prvoj skupini su bile žene koje su rodile u 2005. godini, u drugoj skupini one koje su rodile 2011. 
godine, a u trećoj skupini one koje su rodile 2012. godine. Za dijagnozu gestacijskog dijabetesa 2005. godine korišteni su 
kriteriji Svjetske zdravstvene organizacije, a 2011. i 2012. godine kriteriji IADPSG (International Association of Diabetes and 
Pregnancy Study Groups). U ispitivanim skupinama nije nađena statistički značajna razlika s obzirom na dob rodilja. Nije bilo 
statistički značajne razlike u prosječnoj težini novorođenčadi (p=0,203) među ispitivanim skupinama. Također nije nađena 
statistički značajna razlika niti u načinu dovršenja porođaja (p=0,883). U ispitivanom uzorku carskim rezom rodilo je oko 
30% trudnica. Nije bilo statistički značajne razlike u pojavnosti fetalne hipertrofi je (p=0,348), ali je 2005. godine rođeno više 
djece u skupinama s većom porođajnom masom. Godine 2005. incidencija gestacijskog dijabetesa bila je 2,2%, 2011. godine 
6,6%, a 2012. godine 12%. Razlika u incidenciji gestacijskog dijabetesa posljedica je primjene različitih dijagnostičkih krite-
rija. Novi kriteriji su doprinijeli porastu incidencije gestacijskog dijabetesa, ali i boljoj regulaciji glikemije te posljedično boljoj 
regulaciji fetalnoga rasta.
Ključne riječi: Dijabetes, gestacijski – dijagnostika; Fetusni rast
